Exploration of Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity Following Various Administration Schedules With CYD Tetravalent Dengue Vaccine
Phase of Trial: Phase II
Latest Information Update: 03 May 2017
At a glance
- Drugs CYD TDV (Primary) ; IC 51
- Indications Dengue; Japanese encephalitis
- Focus Pharmacodynamics
- 12 Oct 2016 Status changed from active, no longer recruiting to completed.
- 08 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Aug 2016.